Mend
Latest round
- Series A
Last raised
- Apr 2023
Total raised
- $10M
Investors
- 7
About Mend
, doing business as Mend operates as a biotechnology company focused on nutritional science research. In July 2023, Siphox, Inc. As of 2023, the company has a client base including companies like Petterwood Orthpaedics, Geisinger, Premier, and many more. MEND offers various research and novel targeted solutions by partnering with advisors, partners, and clients. The company’s product portfolio includes Upgraid™, product formulated using natural, organic ingredients used to promote healing and overall well-being. It caters for repairing bones and tissues to enhancing energy levels and supporting healthy muscles.
Who invested in Mend
7 investors across 1 round
See all investors in Mend
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 24, 2023
Amount
$10M
Investors
Questions about Mend
Who invested in Mend?
Mend has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mend raised?
Mend has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mend last raise money?
Mend's most recent round on record is a Series A, in Apr 2023.
What does Mend do?
, doing business as Mend operates as a biotechnology company focused on nutritional science research.
Where is Mend headquartered?
Mend is headquartered in New York, US.
Which VCs invest in companies like Mend?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back food companies at Mend's stage. Their profiles are linked below.
VCs backing food startups at Series A
Raising like Mend? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.